[A case of neonatal Netherton syndrome].

Zhongguo Dang Dai Er Ke Za Zhi

Department of Neonatology, Childrens Hospital of Fudan University/National Childrens Medical Center, Shanghai 201102, China (Zhang S-L, Email: cn).

Published: January 2024

A male infant, aged 6 days, was admitted to the hospital due to respiratory distress and systemic desquamative rash after birth. The infant presented with erythema and desquamative rash, respiratory failure, recurrent infections, chronic diarrhea, hypernatremic dehydration, and growth retardation. Comprehensive treatment, including anti-infection therapy, intravenous immunoglobulin administration, and skin care, resulted in improvement of the rash, but recurrent infections persisted. Second-generation sequencing revealed a homozygous mutation in the gene, consistent with the pathogenic variation of Netherton syndrome. The family opted for palliative care, and the infant died at the age of 2 months after discharge. This report documents a case of Netherton syndrome caused by the gene mutation in the neonatal period, and highlights multidisciplinary diagnosis and therapy for this condition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10817731PMC
http://dx.doi.org/10.7499/j.issn.1008-8830.2307056DOI Listing

Publication Analysis

Top Keywords

desquamative rash
8
recurrent infections
8
netherton syndrome
8
case neonatal
4
neonatal netherton
4
netherton syndrome]
4
syndrome] male
4
male infant
4
infant aged
4
aged days
4

Similar Publications

Introduction: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe hypersensitivity reaction rarely documented in patients with multiple myeloma (MM).

Methods: In our retrospective study of 108 newly diagnosed MM (NDMM) patients from January 2021 to October 2023, we identified four cases of DRESS. The clinical characteristics such as clinical manifestations, laboratory results, treatment and outcome were analyzed.

View Article and Find Full Text PDF

Perforating ENL: A variant of type 2 lepra reaction.

J Clin Tuberc Other Mycobact Dis

February 2025

Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.

Lepra reactions are acute episodic inflammatory reactions that occur during illness due to abrupt changes in the body's immunological response against Mycobacterium leprae. These are of two types, type 1 and type 2. Type 2 reaction is also called Erythema Nodosum Leprosum (ENL).

View Article and Find Full Text PDF

Background: The Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a serious adverse reaction that occurs weeks after the onset of drug exposure. DRESS syndrome is commonly associated with antiseizure drugs, sulfa drugs, and antibiotics.

Case Presentation: This was a case report of a 20-year-old female who suffered from DRESS due to vancomycin with symptoms similar to the Redman syndrome.

View Article and Find Full Text PDF

Purpose Of Review: Arboviral infections caused by Dengue, Zika, and Chikungunya viruses continue to pose a significant global health threat, particularly in endemic regions. This review is timely because of the increasing prevalence of these infections, driven by factors such as urbanization and climate change. Dermatological manifestations of these viruses are crucial for early diagnosis, especially given the overlap in symptoms, which can complicate differential diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • Enfortumab vedotin combined with pembrolizumab (EV+P) shows effectiveness in treating metastatic urothelial carcinoma, but can lead to severe skin reactions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
  • A case is presented of a 67-year-old man who developed SJS/TEN overlap after EV+P therapy, demonstrating the importance of recognizing and treating severe skin toxicities early in patients with additional health issues.
  • Effective management requires quick action with steroids and a multidisciplinary approach, alongside vigilant monitoring and reporting of adverse effects to enhance patient safety.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!